Vertex Pharmaceuticals Incorporated
VRTX
$448.29
$13.123.02%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 4.34B | 3.95B | 3.68B | 3.64B | -988.90M |
| Total Depreciation and Amortization | 186.10M | 178.60M | 175.40M | 174.60M | 176.90M |
| Total Amortization of Deferred Charges | 31.20M | 31.20M | 25.20M | 25.20M | 25.20M |
| Total Other Non-Cash Items | 370.90M | 667.50M | 653.80M | 812.60M | 719.10M |
| Change in Net Operating Assets | -685.90M | -1.20B | -811.50M | -803.60M | -912.60M |
| Cash from Operations | 4.24B | 3.63B | 3.72B | 3.85B | -980.30M |
| Capital Expenditure | -530.30M | -437.60M | -380.80M | -346.70M | -270.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -791.20M | -507.80M | -1.10B | -1.36B | -1.42B |
| Cash from Investing | -1.32B | -945.40M | -1.48B | -1.71B | -1.69B |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.10M | -4.10M | -4.00M | -8.00M | -20.40M |
| Issuance of Common Stock | 138.00M | 127.70M | 108.00M | 108.50M | 114.40M |
| Repurchase of Common Stock | -2.26B | -2.39B | -2.68B | -1.91B | -1.91B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.50M | 2.40M | 2.20M | 2.00M | 2.20M |
| Cash from Financing | -2.12B | -2.26B | -2.58B | -1.81B | -1.82B |
| Foreign Exchange rate Adjustments | 20.10M | 90.90M | 36.30M | 63.20M | 3.50M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 819.50M | 515.60M | -300.30M | 391.00M | -4.48B |